Article Text

Download PDFPDF

986 Distinct macrophage metabolism and phenotypic changes in viral and non-alcoholic fatty liver disease (NAFLD) related hepatocellular carcinoma
  1. Junzhe Zhao1,2,
  2. NEO Shiyong3,4,
  3. See Voon Seow2,
  4. Timothy WH Shuen2,
  5. Farah Tasnim5,
  6. Antoinette SW Fong1,
  7. Caroline G Lee2,6,
  8. Hanry Yu6,7 and
  9. Han Chong Toh2
  1. 1Duke-NUS Medical School: Singapore, Singapore
  2. 2National Cancer Centre Singapore, Singapore
  3. 3Agency for Science, Technology and Research, Singapore
  4. 4Karolinska Institutet, Stockholm, Sweden
  5. 5National Medical Research Council, Singapore
  6. 6National University of Singapore, Singapore
  7. 7Singapore-MIT Alliance for Research and Technology, Singapore
  • Journal for ImmunoTherapy of Cancer (JITC) preprint. The copyright holder for this preprint are the authors/funders, who have granted JITC permission to display the preprint. All rights reserved. No reuse allowed without permission.


Background Different aetiologies of hepatocellular carcinoma (HCC) may influence the tumour microenvironment with implications for immunotherapy. Macrophages, especially the resident Kupffer cells (KCs), are the major PD-L1+ liver cells, and their pro- or anti-inflammatory functions directly affect the progression from chronic inflammation to malignancy. Previous studies have shown that KCs in HCC are associated with poorer survival. We hypothesise that KCs in HCC possess altered lipid metabolism and immunosuppressive phenotype, potentially leading to distinct immunotherapy responses in NAFLD-HCC patients.

Methods Using light sheets microscopy and flow cytometry, we characterise lipid accumulation and macrophage phenotypes in both the tumour and the adjacent non-tumour for 5 viral and 5 non-viral HCC patients. We then validate the association between lipid accumulation and macrophage phenotype in vitro with KCs differentiated from induced pluripotent stem cells (iPSCs) or peripheral blood mononuclear cells (PBMCs). iPSC and patient-derived HCC organoids are then obtained and are co-cultured with KCs and T cells (if needed), which are further characterised with confocal microscopy, multiplex cytokine assay (Luminex) and single cell RNA sequencing (scRNA-seq).

Results Light sheets microscopy of patient samples shows co-localisation between areas of high lipid accumulation and high PD-L1 expression. In the macrophages, flow cytometry confirms a positive association between high lipid accumulation and M2-like phenotype, which is more highlighted in the non-viral HCC patients. In vitro experiments show lipid accumulation in KCs caused by HCC tumour cells, directly contributing to an immunosuppressive phenotype. Strikingly, we also observe increased lipid accumulation in tumour cells and patient-derived tumour organoids, which is KC-specific. Such cycle of lipid accumulation and immunosuppressive changes is possibly mediated by the presence of both pro- and anti- inflammatory cytokines in the culture, as shown by Luminex. This could lead to increased de novo fatty acid synthesis in the KCs following tumour cell/organoid co-culture, as highlighted in scRNA-seq. We have also established an organoid-KC-T cell co-culture model to characterise T cell dysfunction.

Conclusions These results show that lipid accumulation in the HCC macrophages are associated with an immunosuppressive phenotype, which could depend on the disease aetiology. We have constructed an HCC organoid model that recapitulates the patient macrophage phenotypes, providing a platform for downstream mechanistic studies. Co-culture of tumour organoids and KCs lead to lipid accumulation in both cell types, which in turn may contribute to T cell dysfunction. Such effect may be due to the de novo lipogenesis downstream of the cytokine milieu.

Acknowledgements This work was funded by the National Medical Research Council, Singapore, with grant numbers MOH-STaR21nov-0002 and NMRC/OFLCG/003/2018. The authors would like to acknowledge the Flow Cytometry Platform, Singapore Immunology Network, A*STAR, Singapore. Junzhe Zhao would also like to acknowledge Duke-NUS Medical School and the Lee Foundation for funding support, and to acknowledge Dr John Ong (University of Cambridge) for mentoring.

Ethics Approval Patient samples were obtained with ethics approval under the grant NMRC/OFLCG/003/2018, according to the guidelines of the SingHealth Central Institutional Review Board. Participants have given informed consent before taking part.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.